poudre et solvant pour solution injectable (IV)

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Lille, CHU De Martinique

Conditions

Patients (male or female) ≥18 years old with Detrusor overactivity (DO) in multiple sclerosis (MS) or spinal cord injured (SCI).leptospirosis

Phase 2

Multicenter, randomized, open-label non-inferiority trial, comparing two antibiotic therapy periods (3 versus 7 days) in patients with mild leptospirosis and seen at the hospital in 5 French overseas departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte)

Not yet recruitingCTIS2024-518027-30-00

CHU De Martiniqueleptospirosis

Target: 304Updated: 2026-08-13

Phase 3

ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoing intra-vesical botulinum toxin A injections

Not yet recruitingCTIS2024-515107-19-00

Centre Hospitalier Universitaire De LillePatients (male or female) ≥18 years old with Detrusor overactivity (DO) in multiple sclerosis (MS) or spinal cord injured (SCI).

Target: 526Updated: 2025-11-10